ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1428

Subchondral Bone Structure and Pain Behaviors in Complete Freund’s Adjuvant (CFA) Monoarthritis in Mice Treated with Intra-Articular (IA) Neurotoxin

Hollis E. Krug1,2, Joseph Bert3, Fakhar Abbass4, Christopher W. Dorman5, Sandra Frizelle5 and Maren L. Mahowald1,2, 1Medicine, Minneapolis VA Health Care System, Minneapolis, MN, 2Medicine, University of Minnesota, Minneapolis, MN, 3Internal Medicine, Division of Rheumatology, University of Minnesota, Minneapolis, MN, 4Minneapolis VA Health Care System, Minneapolis, MN, 5Research, Minneapolis VA Health Care System, Minneapolis, MN

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Arthritis, Mouse model, pain, subchondral bone and therapy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Pain: Basic and Clinical Aspects Poster

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Bone histomorphometry can define OA changes in rodents and in Antigen-Induced arthritis (AIA) in rats. We produced painful inflammatory monoarthritis in mouse knees with IA CFA. IA neurotoxins reduced pain behaviors in murine CFA arthritis. Ttreatment with anti-nerve growth factor in humans rarely produced rapid joint destruction requiring arthroplasty. We used micro CT of knees to correlate pain behaviors with histomorphometric bone changes and to determine whether IA neurotoxin treatment worsened changes.

Methods:

Chronic Inflammatory arthritis was produced by IA injection of 30 µl CFA into the left knee of C57BL6 male mice 3 weeks prior to pain behavior testing using evoked pain score (EPS) and automated dynamic weight bearing (ADWB) device. EPS was a tally of fights and vocalizations/min with knee palpation at 15.6 psi. Percent weight and time on each limb was measured with ADWB apparatus (Bioseb, Vitrolles, France). IA vanilloids resiniferatoxin (RTX) and capsaicin (CAP) (10µl each of 0.001%RTX, 0.003% RTX or 0.01% CAP) were given 7 days prior to pain testing. IA botulinum toxin A (10µl 0.02 IU) was injected 3 days before testing. Knees were imaged on a micro-CT scanner (micro-CT40; Scanco Medical AG, Bassersdorf, Switzerland). Subchondral trabecular bone volume fraction (BV/TV), trabecular thickness (Tb.Th in µm), trabecular spacing (Tb.S in µm), and number (Th.N in 1/mm) were calculated from coronal slices using 3D Calculator (Erasmus Medical Center, Rotterdam, Netherlands).

Results:

Arthritis pain behavior was low in naïve mice – EPS (0.5) and ADWB proportions for weight (40.9%) and time (97.4%) were normal. IA CFA arthritis significantly increased EPS (2.5) and decreased ADWB for weight (34.1) and time (92.3). Arthritic knees had significantly reduced BV/TV (42.4 vs 50.3%), Tb.Th (252 vs 352 µm), and increased Tb.S (183 vs 112 µm) compared to naive knees. There was a significant negative linear relationship between EPS and BV/TV (R2= 0.626, p<.05) with higher EPS when BV/TV was lower. ADWB measures trended in the same direction but were not statistically significant. IA neurotoxin treatments did not decrease BV/TV or Tb.Th or increase Tb.S. High dose IA-RTX in CFA mice normalized Tb.Th but not Tb.S or BV/TV.

Conclusion:

We confirmed that IA CFA monoarthritis increased evoked and spontaneous pain behaviors. MicroCT measured significant changes in BV/TV proportion, Tb.Th and Tb.Sp in CFA inflammatory arthritis. These findings are consistent with bone histomorphometry in rats with AIA. IA neurotoxins treatments with BOT, RTX and CAP did not worsen these subchondral changes. Interestingly high dose IA-RTX actually normalized Tb.Th. The negative relationship between BV/TV proportion and pain behaviors (ie increased pain with lowest BV/TV) suggests that more severe arthritic subchondral structural changes may be associated with increased pain behaviors.


Disclosure: H. E. Krug, None; J. Bert, None; F. Abbass, None; C. W. Dorman, None; S. Frizelle, None; M. L. Mahowald, None.

To cite this abstract in AMA style:

Krug HE, Bert J, Abbass F, Dorman CW, Frizelle S, Mahowald ML. Subchondral Bone Structure and Pain Behaviors in Complete Freund’s Adjuvant (CFA) Monoarthritis in Mice Treated with Intra-Articular (IA) Neurotoxin [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/subchondral-bone-structure-and-pain-behaviors-in-complete-freunds-adjuvant-cfa-monoarthritis-in-mice-treated-with-intra-articular-ia-neurotoxin/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/subchondral-bone-structure-and-pain-behaviors-in-complete-freunds-adjuvant-cfa-monoarthritis-in-mice-treated-with-intra-articular-ia-neurotoxin/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology